A Ferroptosis-Related Gene Prognostic Index to Predict Temozolomide Sensitivity and Immune Checkpoint Inhibitor Response for Glioma
Background: Gliomas are highly lethal brain tumors. Despite multimodality therapy with surgery, radiotherapy, chemotherapy, and immunotherapy, glioma prognosis remains poor. Ferroptosis is a crucial tumor suppressor mechanism that has been proven to be effective in anticancer therapy. However, the i...
Main Authors: | Yonghua Cai, Xianqiu Liang, Zhengming Zhan, Yu Zeng, Jie Lin, Anqi Xu, Shuaishuai Xue, Wei Xu, Peng Chai, Yangqi Mao, Zibin Song, Lei Han, Jianqi Xiao, Ye Song, Xian Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-01-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcell.2021.812422/full |
Similar Items
-
A Potential Mechanism of Temozolomide Resistance in Glioma–Ferroptosis
by: Zhifang Hu, et al.
Published: (2020-06-01) -
Abnormally Expressed Ferroptosis-Associated FANCD2 in Mediating the Temozolomide Resistance and Immune Response in Glioblastoma
by: Liying Song, et al.
Published: (2022-06-01) -
IRF2-ferroptosis related gene is associated with prognosis and EMT in gliomas
by: Shiao Tong, et al.
Published: (2022-12-01) -
Albumin-bound paclitaxel augment temozolomide treatment sensitivity of glioblastoma cells by disrupting DNA damage repair and promoting ferroptosis
by: Shanqiang Qu, et al.
Published: (2023-10-01) -
β-elemene combined with temozolomide in treatment of brain glioma
by: Xiaomin Zhang, et al.
Published: (2021-12-01)